VistaGen Therapeutics, Inc. (VSTA) Business Strategy Centers on Cutting-Edge Stem Cell Technology
VistaGen Therapeutics employs the expertise of company co-founder and renowned Canadian stem cell scientist Dr. Gordon Keller, as well as co-founder, president, and chief scientific officer Dr. Ralph Snodgrass. Human Clinical Trials in a Test Tube™, the company’s human pluripotent stem cell (hPSC) technology platform, was developed using a combination of proprietary and exclusively licensed hPSC technologies, including those originating from two decades of research by Drs. Keller and Snodgrass. The platform’s underlying technologies enable controlled differentiation of hPSCs into mature human cells specific to VistaGen’s current and potential predictive toxicology, drug metabolism, drug rescue, and regenerative cell therapy programs…